Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

by Anna Azvolinsky

Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

by Anna Azvolinsky

Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

by Ashley P. Taylor

The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.

by Anna Azvolinsky

A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.

by Brad Jones

In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

by Kate Yandell

At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

by Kate Yandell

Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

by Cheryl Platzman Weinstock